MARKET

NVAX

NVAX

Novavax Inc
NASDAQ
10.55
-0.74
-6.55%
Opening 13:02 01/30 EST
OPEN
11.16
PREV CLOSE
11.29
HIGH
11.25
LOW
10.48
VOLUME
4.50M
TURNOVER
27.40M
52 WEEK HIGH
101.39
52 WEEK LOW
8.75
MARKET CAP
896.51M
P/E (TTM)
-0.6115
1D
5D
1M
3M
1Y
5Y
$1,000 Invested In 4 Of The 5 Vaccine Developers Back When WHO Declared COVID-19 An Emergency Yielded Returns
Benzinga · 2h ago
WHO maintains public health emergency on COVID but sees 'inflexion point' ahead
Seeking Alpha · 6h ago
Bank of America Securities Reaffirms Their Sell Rating on Novavax (NVAX)
TipRanks · 8h ago
Novavax: The Vaccine Battle Continues With Gavi
Seeking Alpha · 2d ago
COVID-19 Omicron subvariant XBB.1.5 now accounts for 61% of cases nationwide
Seeking Alpha · 2d ago
UPDATE 1-FDA advisers back the same COVID vaccine for initial shots, boosters
Reuters · 3d ago
FDA advisory panel suggests regular bivalent COVID immunization
Seeking Alpha · 3d ago
BRIEF-FDA Advisers Vote In Favor Of Using Same Coronavirus Variant For Initial COVID Vaccine Doses And Boosters
Reuters · 3d ago
More
About NVAX
Novavax, Inc., along with its wholly owned subsidiaries, Novavax AB and Novavax CZ, is a biotechnology company. The Company promotes improved health globally through the discovery, development, and commercialization of vaccines to prevent serious infectious diseases. Its recombinant technology platform harnesses the power and speed of genetic engineering to produce immunogenic nanoparticles designed to address urgent global health needs. The vaccine candidates in its near-term pipeline, including both coronavirus vaccine candidate (NVX-CoV2373) and seasonal quadrivalent influenza vaccine candidate (NanoFlu), which are genetically engineered, three-dimensional nanostructures of recombinant proteins critical to disease pathogenesis. NVX-CoV2373 is marketed under the brand name of Covovax or as Nuvaxovid COVID-19 Vaccine (SARS-CoV-2 rS [Recombinant, adjuvanted]).

Webull offers kinds of Novavax Inc stock information, including NASDAQ:NVAX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NVAX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NVAX stock methods without spending real money on the virtual paper trading platform.